Cargando…

Vesicular Dysfunction and the Pathogenesis of Parkinson’s Disease: Clues From Genetic Studies

Parkinson’s disease (PD) is a common age-related neurodegenerative disorder with disabling motor symptoms and no available disease modifying treatment. The majority of the PD cases are of unknown etiology, with both genetics and environment playing important roles. Over the past 25 years, however, g...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ebanks, Kirsten, Lewis, Patrick A., Bandopadhyay, Rina
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2020
Materias:	Neuroscience
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6960401/ https://www.ncbi.nlm.nih.gov/pubmed/31969802 http://dx.doi.org/10.3389/fnins.2019.01381

Ejemplares similares

In silico comparative analysis of LRRK2 interactomes from brain, kidney and lung
por: Verma, Amrita, et al.
Publicado: (2021)

Role of Chaperone-Mediated Autophagy Dysfunctions in the Pathogenesis of Parkinson’s Disease
por: Sala, Gessica, et al.
Publicado: (2016)

Pathological Relevance of Post-Translationally Modified Alpha-Synuclein (pSer87, pSer129, nTyr39) in Idiopathic Parkinson’s Disease and Multiple System Atrophy
por: Sonustun, Berkiye, et al.
Publicado: (2022)

Vesicular dysfunction and pathways to neurodegeneration
por: Lewis, Patrick A.
Publicado: (2021)

Individual differences in approach-avoidance aptitude: some clues from research on Parkinson’s disease
por: Costa, Alberto, et al.
Publicado: (2015)

Sequential Extraction of Soluble and Insoluble Alpha-Synuclein from Parkinsonian Brains
por: Bandopadhyay, Rina
Publicado: (2016)

Regulation and targeting of enzymes mediating Parkinson's disease pathogenesis: focus on Parkinson's disease kinases, GTPases, and ATPases
por: Taymans, Jean-Marc, et al.
Publicado: (2014)

A mini-review of the role of vesicular glutamate transporters in Parkinson’s disease
por: Zhao, Cheng, et al.
Publicado: (2023)

Genetic perspective on the synergistic connection between vesicular transport, lysosomal and mitochondrial pathways associated with Parkinson’s disease pathogenesis
por: Smolders, Stefanie, et al.
Publicado: (2020)

The energy cost of action potential propagation in dopamine neurons: clues to susceptibility in Parkinson's disease
por: Pissadaki, Eleftheria K., et al.
Publicado: (2013)

Leg restlessness and hyperparathyroidism in Parkinson's disease, a further clue to RLS pathogenesis?
por: Marano, Massimo, et al.
Publicado: (2023)

Different transporter systems regulate extracellular GABA from vesicular and non-vesicular sources
por: Song, Inseon, et al.
Publicado: (2013)

Imaging Single Photons and Intrinsic Optical Signals for Studies of Vesicular and Non-Vesicular ATP Release from Axons
por: Fields, R. Douglas
Publicado: (2011)

Genetic studies provide clues on the pathogenesis of idiopathic pulmonary fibrosis
por: Kropski, Jonathan A., et al.
Publicado: (2013)

Glucocerebrosidase Mutations Cause Mitochondrial and Lysosomal Dysfunction in Parkinson’s Disease: Pathogenesis and Therapeutic Implications
por: Zheng, Wei, et al.
Publicado: (2022)

Gut Inflammation in Association With Pathogenesis of Parkinson’s Disease
por: Chen, Qian-Qian, et al.
Publicado: (2019)

Editorial: The Role of Lipids in the Pathogenesis of Parkinson's Disease
por: Baekelandt, Veerle, et al.
Publicado: (2020)

Motor dysfunction in cerebellar Purkinje cell-specific vesicular GABA transporter knockout mice
por: Kayakabe, Mikiko, et al.
Publicado: (2014)

SIAH proteins regulate the degradation and intra‐mitochondrial aggregation of PINK1: Implications for mitochondrial pathology in Parkinson's disease
por: Abd Elghani, Fatimah, et al.
Publicado: (2022)

Neuronally enriched microvesicle RNAs are differentially expressed in the serums of Parkinson’s patients
por: Aguilar, Morris A., et al.
Publicado: (2023)

Urological dysfunctions in patients with Parkinson’s disease: clues from clinical and non-invasive urological assessment
por: Valentino, Francesca, et al.
Publicado: (2018)

Editorial: Biomarkers and Pathogenesis of Alpha-Synuclein in Parkinson's Disease
por: Li, Puyu, et al.
Publicado: (2021)

Parkinson’s disease-implicated kinases in the brain; insights into disease pathogenesis
por: Dzamko, Nicolas, et al.
Publicado: (2014)

Dysfunction of Cellular Proteostasis in Parkinson’s Disease
por: Lehtonen, Šárka, et al.
Publicado: (2019)

The epidemiology of inflammatory bowel disease: Clues to pathogenesis?
por: Borowitz, Stephen M.
Publicado: (2023)

From Synaptic Dysfunction to Neuroprotective Strategies in Genetic Parkinson’s Disease: Lessons From LRRK2
por: Mancini, Andrea, et al.
Publicado: (2020)

Mitochondrial Dysfunction in Parkinson’s Disease: From Mechanistic Insights to Therapy
por: Gao, Xiao-Yan, et al.
Publicado: (2022)

Cross-Talk Between Mitochondria and Proteasome in Parkinson's Disease Pathogenesis
por: Branco, Diogo Martins, et al.
Publicado: (2010)

α-synuclein pathogenesis in hiPSC models of Parkinson’s disease
por: Baena-Montes, Jara M., et al.
Publicado: (2021)

The role of the endolysosomal pathway in α-synuclein pathogenesis in Parkinson’s disease
por: Smith, Jessica K., et al.
Publicado: (2023)

Corrigendum: High levels of Bifidobacteriaceae are associated with the pathogenesis of Parkinson's disease
por: Zuo, ShuJia, et al.
Publicado: (2023)

Dysfunctional Mitochondria and Mitophagy as Drivers of Alzheimer’s Disease Pathogenesis
por: Chakravorty, Anushka, et al.
Publicado: (2019)

Mitochondrial Dysfunction in Parkinson's Disease: Pathogenesis and Neuroprotection
por: Mounsey, Ross B., et al.
Publicado: (2010)

The Role of Astrocyte Dysfunction in Parkinson’s Disease Pathogenesis
por: Booth, Heather D.E., et al.
Publicado: (2017)

Noradrenergic Dysfunction in Alzheimer's and Parkinson's Diseases—An Overview of Imaging Studies
por: Peterson, Andrew C., et al.
Publicado: (2018)

Executive dysfunction in Parkinson’s disease and timing deficits
por: Parker, Krystal L., et al.
Publicado: (2013)

Dysfunction of Synaptic Vesicle Endocytosis in Parkinson’s Disease
por: Zou, Li, et al.
Publicado: (2021)

ClueDepth Grasp: Leveraging positional clues of depth for completing depth of transparent objects
por: Hong, Yuanlin, et al.
Publicado: (2022)

RNA Editing—Systemic Relevance and Clue to Disease Mechanisms?
por: Meier, Jochen C., et al.
Publicado: (2016)

Neuroprotective Therapy in Parkinson's Disease: Current Status and New Directions from Experimental and Genetic Clues
por: Lin, William, et al.
Publicado: (2005)

Cannot write session to /tmp/vufind_sessions/sess_9qba7sq8osouste5p680qamla8